Is Gritstone bio, Inc. (GRTS) a Buy, Sell, or Hold?
NASDAQ : GRTS
Gritstone bio, Inc. — Institutional Ownership
$0.0322 USD
-$0.01 (-31.78%)
- Volume
- 55.25M
- Average Volume
- 17.68M
- Market Capitalization
- $3.8M
- P/E Ratio
- -0.03
- Dividend Yield
- 0.00%
- Price Target
- $5.00
- Year High
- $3.17
- Year Low
- $0.03
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.20
Institutional Ownership Summary
Institutional Ownership %
%
Investors Holding
change: 0.0 | last:
Increased Positions
change: 0.0 | last:
Reduced Positions
change: 0.0 | last:
New Positions
change: 0.0 | last:
Sold Positions
change: 0.0 | last:
Total Calls
-
Total Puts
-
Put-Call Ratio
change: 0.0 | last:
Total Invested
-
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2025-02-14 | Redmile Group, LLC | 13.16M | 8.20% |
| 2024-10-07 | RedCo II Master Fund, L.P. | 8.2M | 6.20% |
| 2024-02-08 | Morgan Stanley | 5.52M | 5.80% |
| 2024-02-08 | Morgan Stanley & Co. LLC | 5.42M | 5.70% |
| 2024-01-29 | (1) BlackRock, Inc. | 5.87M | 6.20% |
| 2022-11-01 | Point72 Capital Advisors, Inc. | 6.46M | 4.00% |
| 2022-11-01 | Cubist Systematic Strategies, LLC | 147.41K | 4.00% |
| 2022-11-01 | Point72 Asset Management, L.P. | 6.46M | 4.00% |
| 2022-11-01 | Steven A. Cohen | 6.61M | 4.00% |
| 2022-07-08 | (1) BlackRock, Inc. | 1.91M | 2.60% |
| 2022-02-14 | EcoR1 Capital Fund Qualified, L.P. | 5.74M | 11.00% |
| 2022-02-14 | EcoR1 Capital, LLC | 6.32M | 11.00% |
| 2022-02-14 | Oleg Nodelman | 6.32M | 11.00% |
| 2022-02-14 | Avidity Capital Partners (GP) LLC | 6.99M | 9.90% |
| 2022-02-14 | Avidity Capital Partners Fund (GP) LP | 6.99M | 9.90% |
| 2022-02-14 | Avidity Partners Management (GP) LLC | 6.99M | 9.90% |
| 2022-02-14 | Avidity Partners Management LP | 6.99M | 9.90% |
| 2022-02-14 | Avidity Master Fund LP | 6.23M | 8.80% |
| 2022-02-11 | STATE STREET CORPORATION | 3.67M | 5.40% |
| 2022-02-14 | David Witzke | 6.99M | 9.90% |
| 2022-02-14 | Michael Gregory | 6.99M | 9.90% |
| 2022-02-04 | (1) BlackRock, Inc. | 3.79M | 5.60% |
| 2021-09-21 | Alan Frazier | 1.04M | 1.90% |
| 2021-02-16 | 13G | 207.23K | 0.40% |
| 2021-02-16 | 13G | 207.23K | 0.40% |
| 2021-02-16 | 13G | 207.23K | 0.40% |
| 2021-02-16 | 13G | 1.35M | 2.80% |
| 2021-02-16 | 13G | 1.35M | 2.80% |
| 2021-02-16 | 13G | 1.35M | 2.80% |
| 2021-02-16 | 13G | 2.9M | 6.10% |
| 2021-02-16 | 13G | 81908.0 | 0.20% |
| 2021-02-16 | 13G | 90756.0 | 0.20% |
| 2021-02-16 | 13G | 2.72M | 5.70% |
| 2021-02-16 | The Column Group II GP, LP | - | 0.00% |
| 2021-02-16 | The Column Group II, LP | - | 0.00% |
| 2021-02-16 | David V. Goeddel | - | 0.00% |
| 2021-02-16 | Peter Svennilson | - | 0.00% |
| 2021-02-10 | Wellington Management Group LLP | 4.33M | 10.35% |
| 2021-02-10 | Wellington Investment Advisors Holdings LLP | 4.33M | 10.35% |
| 2021-02-10 | Wellington Group Holdings LLP | 4.33M | 10.35% |
| 2021-02-10 | Wellington Management Company LLP | 4.02M | 9.62% |
| 2021-02-04 | Frazier Healthcare VII-A, L.P. | 228.62K | 0.60% |
| 2021-02-04 | Nathan Every | 1.04M | 2.80% |
| 2021-02-04 | Nader Naini | 1.04M | 2.80% |
| 2021-02-04 | Brian Morfitt | 1.04M | 2.80% |
| 2021-02-04 | FHM VII, L.P. | 1.03M | 2.70% |
| 2021-02-04 | FHM VII, L.L.C. | 1.03M | 2.70% |
| 2021-02-04 | Frazier Healthcare VII, L.P. | 802.26K | 2.10% |
| 2021-02-04 | James Topper | 1.09M | 2.90% |
| 2021-02-04 | Alan Frazier | 1.04M | 2.80% |
| 2021-02-04 | Patrick Heron | 1.09M | 2.90% |
| 2021-02-01 | Wellington Management Funds (Ireland) plc | 2.46M | 5.88% |
| 2021-01-11 | BVF Inc. | 2.7M | 6.50% |
| 2021-01-11 | Biotechnology Value Fund, L.P. | 1.43M | 3.40% |
| 2021-01-11 | BVF Partners OS Ltd. | 172.28K | 1.00% |
| 2021-01-11 | BVF GP HOLDINGS LLC | 2.47M | 5.90% |
| 2021-01-11 | Mark N. Lampert | 2.7M | 6.50% |
| 2021-01-11 | BVF Partners L.P. | 2.7M | 6.50% |
| 2021-01-11 | BVF I GP LLC | 1.43M | 3.40% |
| 2021-01-11 | Biotechnology Value Fund II, L.P. | 1.05M | 2.50% |
| 2021-01-11 | BVF II GP LLC | 1.05M | 2.50% |
| 2021-01-11 | Biotechnology Value Trading Fund OS LP | 172.28K | 1.00% |
| 2021-01-04 | EcoR1 Capital, LLC | 4.88M | 11.00% |
| 2021-01-04 | Oleg Nodelman | 4.88M | 11.00% |
| 2021-01-04 | EcoR1 Capital Fund Qualified, L.P. | 4.93M | 11.00% |
| 2020-12-28 | David Witzke | 4.53M | 9.90% |
| 2020-12-28 | Avidity Capital Partners (GP) LLC | 4.53M | 9.90% |
| 2020-12-28 | Avidity Master Fund LP | 4.55M | 9.90% |
| 2020-12-28 | Avidity Capital Partners Fund (GP) LP | 4.53M | 9.90% |
| 2020-12-28 | Michael Gregory | 4.53M | 9.90% |
| 2020-12-28 | Avidity Partners Management (GP) LLC | 4.53M | 9.90% |
| 2020-12-28 | Avidity Partners Management LP | 4.53M | 9.90% |
| 2020-02-07 | (1) BlackRock, Inc. | 2M | 5.60% |
| 2020-02-06 | Casdin Partners Master Fund, L.P. | 2.16M | 6.00% |
| 2020-02-06 | Casdin Partners GP, LLC | 2.16M | 6.00% |
| 2020-02-06 | Casdin Capital, LLC | 2.16M | 6.00% |
| 2020-02-06 | Eli Casdin | 2.16M | 6.00% |
| 2019-11-21 | Casdin Capital, LLC | 1.9M | 5.30% |
| 2019-11-21 | Eli Casdin | 1.9M | 5.30% |
| 2019-11-21 | Casdin Partners Master Fund, L.P. | 1.9M | 5.30% |
| 2019-11-21 | Casdin Partners GP, LLC | 1.9M | 5.30% |
| 2019-02-14 | Versant Ophthalmic Affiliates Fund I, L.P. | 90756.0 | 0.30% |
| 2019-02-14 | Versant Venture Capital V (Canada) LP | 207.23K | 0.70% |
| 2019-02-14 | Versant Ventures V GP-GP (Canada), Inc. | 207.23K | 0.70% |
| 2019-02-14 | Versant Ventures V (Canada), L.P. | 207.23K | 0.70% |
| 2019-02-14 | Jeremy C. Green | 2.27M | 7.80% |
| 2019-02-14 | Versant Venture Capital V, L.P. | 2.72M | 9.40% |
| 2019-02-14 | Versant Affiliates Fund V, L.P. | 81908.0 | 0.30% |
| 2019-02-14 | Versant Ventures V, LLC | 2.9M | 10.00% |
| 2019-02-14 | Redmile Group, LLC | 2.27M | 7.80% |
| 2019-02-13 | FMR LLC | 2.9M | 10.00% |
| 2019-02-13 | Abigail P. Johnson | 2.9M | 10.00% |
| 2018-10-03 | Redmile Group, LLC | 2.24M | 7.80% |
| 2018-10-03 | Jeremy C. Green | 242.63K | 7.80% |
GRTS Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2023-12-31 | $2.04 | 115.53M | $235.68M | $65.28M | $104.78M | $275.17M |
| 2022-12-31 | $3.45 | 90.92M | $313.67M | $55.5M | $40.32M | $298.49M |
| 2021-12-31 | $12.86 | 78.89M | $1.01B | $93.29M | $26.42M | $947.6M |
| 2020-12-31 | $3.94 | 37.79M | $148.9M | $170.06M | $25.1M | $3.94M |
| 2019-12-31 | $8.97 | 33.55M | $300.99M | $57.41M | $23.49M | $267.07M |
| 2018-12-31 | $15.45 | 8.92M | $137.8M | $52.18M | $10.49M | $96.11M |
| 2017-12-31 | $14.24 | 20.09M | $286.1M | $39.01M | $10.52M | $257.61M |
| 2016-12-31 | $14.24 | 20.09M | $286.1M | $12.41M | -$ | $273.69M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2024-06-30 | $0.58 | 143.3M | $83.11M | $52.17M | $102.49M | $133.43M |
| 2024-03-31 | $2.35 | 118.39M | $278.22M | $43.64M | $103.28M | $337.86M |
| 2023-12-31 | $2.04 | 97.59M | $199.07M | $65.28M | $104.78M | $238.56M |
| 2023-09-30 | $1.72 | 115.34M | $198.39M | $29.54M | $95.3M | $264.15M |
| 2023-06-30 | $1.95 | 114.93M | $224.11M | $41.41M | $95.38M | $278.08M |
| 2023-03-31 | $2.78 | 114.42M | $318.1M | $47.13M | $48.78M | $319.75M |
| 2022-12-31 | $3.45 | 86.89M | $299.79M | $55.5M | $40.32M | $284.61M |
| 2022-09-30 | $2.57 | 85.62M | $220.04M | $64.91M | $42.36M | $197.49M |
| 2022-06-30 | $2.42 | 86.45M | $209.21M | $65.69M | $24.97M | $168.49M |
| 2022-03-31 | $4.12 | 86.28M | $355.46M | $69.16M | $25.58M | $311.88M |
| 2021-12-31 | $12.86 | 77.78M | $1B | $93.29M | $26.42M | $933.32M |
| 2021-09-30 | $10.80 | 77.78M | $839.98M | $131.42M | $27.3M | $735.85M |